A Case of Refractory Acute Angle Closure Glaucoma after an Intravitreal Bevacizumab Injection

A cute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report

BACKGROUND Intravitreal injection is widely used to treat retinal vein occlusion, and acute angle closure (AAC) is an exceptional complication of intravitreal injection. The authors report a case of AAC that occurred immediately after administering intravitreal bevacizumab to treat branch retinal vein occlusion (BRVO). CASE PRESENTATION A 65-year-old woman was referred to the retina clinic of...

Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.

Neovascular glaucoma is a secondary glaucoma with grave prognosis which follows ischemic retinal disorders in the majority of cases. Mediators that induce new vessel formation such as the vascular endothelial growth factor-A seem to play a key role in the pathophysiology of this condition. Herein, we report 2 cases with neovascular glaucoma secondary to ischemic central retinal vein occlusion w...

Incidence of acute endophthalmitis after office based intravitreal bevacizumab injection.

The burden of intravitreal injections has increased tremendously over the past few years. Since traditionally the operation theatre setup is currently used for this procedure, it is increasingly becoming difficult to manage such a patient load in the theatres. To overcome this challenge, office-based setup for intravitreal injection was started. This study was planned to determine the incidence...

Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm.

Botulinum toxin inhibits acetylcholine release and therefore could cause mydriasis. We report a case of acute angle-closure glaucoma which occurred shortly after a series of injections of botulinum toxin round the eyelids for blepharospasm.

Citalopram Associated with Acute Angle- Closure Glaucoma: a Case Report